Skip to main content

Table 3 Clinical outcomes in-hospital period and follow up.

From: Concomitant renal insufficiency and diabetes mellitus as prognostic factors for acute myocardial infarction

  Group I (n = 5702) Group II (n = 1731) Group III (n = 1432) Group IV (n = 1044) p Value
      Overall Linear†
In-hospital outcomes (n = 9905)       
   In-hospital death (%) 168(3) 66(4) 249(18) 185(18) < 0.001 < 0.001
1-month outcomes       
   Composite MACE (%) 327 (5.7) 128(7.4) 317(22.2) 257(24.6) < 0.001 < 0.001
   Death (%) 225(3.9) 84(4.9) 296(20.7) 226(21.6) < 0.001 < 0.001
   MI (%) 28(0.5) 12(0.7) 4(0.3) 19(1.8) < 0.001 0.001
   Re-PCI (%) 57(1.0) 21(1.2) 16(1.1) 7(0.7) 0.559 0.649
   CABG (%) 17(0.3) 11(0.6) 1(0.1) 5(0.5) 0.039 0.807
12-month outcomes       
   Composite MACE (%) 715 (12.5) 271 (15.7) 436 (30.5) 381 (36.5)‡§ < 0.001 < 0.001
   Death (%) 287(5.0) 117 (6.8) 361 (25.3) 287 (27.5) < 0.001 < 0.001
   MI (%) 44(0.8) 20 (1.2) 10 (0.7) 25 (2.4)‡§ < 0.001 < 0.001
   Re-PCI (%) 385(6.3) 120 (6.9) 59 (4.1) 62 (5.9)§ 0.006 0.082
   CABG (%) 26 (0.5) 14 (0.8) 6 (0.4) 7 (0.7) 0.280 0.455
  1. Groups are as in Table 1.
  2. Abbreviations: MACE, major adverse cardiac event; MI, myocardial infarction; Re-PCI, target lesion revascularization; CABG, coronary artery bypass graft.
  3. †Statistical significance for linear-by-linear association between categorical variables calculated using chi-square-test for trend.
  4. p < 0.05 Compared with Group I.
  5. p < 0.05 Compared with Group II.
  6. § p < 0.05 Compared with Group III.